On September 9, 2024, the second phase of the "BioPR Overseas Challenge and Experience Sharing Meeting" of Zhangjiang Zhishang Chuangxiang Center was successfully held.
The event was guided by the Shanghai Biomedical Industry Promotion Center, and co-hosted by Zhangjiang Zhishang with R&D customers and the China Innovative Biopharmaceutical Public Relations Alliance (bioPR). The event brought together leading figures in the pharmaceutical communication industry to discuss the opportunities and challenges for innovative pharmaceutical companies to go overseas through a series of in-depth speeches and roundtable forums.
The guests focused on the problem of "public relations and communication of innovative pharmaceutical companies going overseas", and shared strategic communication strategies and creative content, so that the innovation of biopharmaceutical companies can not only be known, but also resonate and respect.
During the sharing event, Tanisha Carino, Partner of Brunswick Group, shared how to find certainty in the development of the pharmaceutical industry in the current uncertain international environment. Chen Chen, Senior Director of Marketing & Commercial at PharmaBlock, shared his experience in applying the trinity of PR, BD and Marketing to increase the influence of the company's brand. Zhang Wangjun· Corporate Cooperation Manager of Springer Nature, shared strategies for improving the academic image of innovative pharmaceutical companies. Yan Sun, Senior Director of Corporate Communications at GenScript Biotech, shared how to enhance corporate brands through effective PR in going global. In the roundtable discussion, Wu Jie, former Vice President of Communications of BeiGene Greater China, Zhang Hui, Director of Corporate Communications and Public Affairs of Yahong Pharmaceutical, and Sun Yan, Senior Director of Corporate Communications of GenScript Biotech, fully discussed the strategy and scale of PR in the global expansion of enterprises.
As a key project of Shanghai Real Estate Group's park focusing on the biomedical industry, Zhangjiang Zhishang will strive to build an important position for the future development of biomedicine in Shanghai, and continue to promote the innovation and development of the biomedical industry.
The project will uphold the concept of co-construction and sharing, strive for the two-way empowerment of the park and technology enterprises, and form a smart, innovative and efficient industrial ecology.
New industry "convergence field", cross-border integration "linker"
The "Zhangjiang Zhishang Plan" aims to provide a multi-dimensional industry exchange and sharing platform with the Ce+Hub as the carrier. "Take activities/events as the path to connect multiple industries and achieve cross-border innovation. Through diversified cross-border activities, science and technology × industry× design × art fields, policy × market× industry × media topics, explore new models of future science and technology industrial parks, inject new vitality into regional development, lead the innovation and reform of urban development models, and work together to create a new future!